NCT07901153
Platelet-Rich Plasma, Hyaluronic Acid, or Their Combination for Knee Osteoarthritis in Athletes
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria shortened, about 30 words Show 4 more changesShow less
- Interventions modified
- Secondary endpoints: details revised at 2 of 12 entries
- Study description expanded, about 83 words
- Site contact updated
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (12)
Show 7 moreShow less
Arms and interventions
Single session: ultrasound-guided intra-articular injection of approximately 5 mL of leukocyte-poor PRP (at least 1,000,000 platelets/uL and at least 5 billion platelets), followed in the same session by a single dose of high molecular weight hyaluronic acid.
Single session: ultrasound-guided intra-articular injection of approximately 5 mL of leukocyte-poor PRP (at least 1,000,000 platelets/uL and at least 5 billion platelets).
Single session: ultrasound-guided intra-articular injection of a single dose of high molecular weight hyaluronic acid. Blood is also collected to preserve participant blinding.
Biologicals: Leukocyte-Poor Platelet-Rich Plasma
Devices: High Molecular Weight Hyaluronic Acid
Sites
1 site in 1 country
- Institute of Orthopaedics and Traumatology, Hospital das Clinicas, University of Sao Paulo School of Medicine (IOT-HCFMUSP)São Paulo, São Paulo, Brazil